The focus this week was on smaller startups with big ideas: AIATELLA raised funding for its cardiovascular imaging technology, while Vively secured funding for the rollout of its program tacking pre-diabetes. Below we share rounds you wouldn’t want to ignore.
ArcheHealth secures $6.7m for AI healthcare platform
ArcheHealth’s platform uses AI to offer hospitals insights into the costs of delivering care at the patient level, helping reduce costs and enhance operational performance.
The $6.7m seed funding round saw participation from Martin Ventures, LRVHealth, and Texas Health Resources.
CEO Ralph Keiser
Cosm Medical Raises Seed+ Financing
Canada-based Cosm Medical raised an undisclosed amount in Seed+ funding, led by iGan Partners with participation from Spring Impact Capital and angels.
The company intends to use the funds to accelerate its U.S. expansion, clinical validation, and commercial growth.
Founder and CEO Derek Sham
BrainsWay invests $5m in Stella Mental Health to expand access to Deep TMS therapy
BrainsWay made a $5 million minority-stake investment in Stella MSO.
The strategic equity financing agreement aims to support interventional psychiatry providers and increase access to BrainsWay’s FDA-cleared Deep Transcranial Magnetic Stimulation therapy.
CEO Michael Gershenzon
3DBioFibR Raises $3m to Advance Next-Gen Biopolymer Fiber Manufacturing Platform
3DBioFibR raised $3 million equity financing round, which drew participation from both new and existing investors, including AoA Innovation Fund, Build Ventures, Invest Nova Scotia, and Concrete Ventures.
The raise will support the company in improving operational scale and deepening its role as a critical supplier of next-gen biomaterials.
CEO Kevin Sullivan
AIATELLA raises €2m for AI-powered cardiovascular imaging tools
Startup AIATELLA secured €2m in funding to accelerate its AI-powered cardiovascular imaging technology, aimed to improve imaging workflows.
The round was led by Helsinki-based Nordic Science Investments, with Specialist VC, Harjavalta Ventures, Business Finland, and a syndicate of angel investors also joined.
Co-founder and CEO Jack Parker
Vively metabolises $1.6m Seed round
The round was led by Archangel Ventures with support from Bupa Ventures, the VC arm of not-for-profit private health insurer Bupa, and others.
The metabolic health monitoring platform combines real-time glucose monitoring with AI-driven insights and coaching to help prevent diseases.
CEO Tim Veron
